Europe Enteral and Parenteral Medical Nutrition Market

The Europe enteral and parenteral medical nutrition market is expected to grow from US$ 6,472.35 million in 2023 to US$ 9,054.89 million by 2028. It is estimated to grow at a CAGR of 6.9% from 2023 to 2028.   

Increasing Cases of Malnutrition and Premature Births Fuels Europe Enteral and Parenteral Medical Nutrition Market

Malnutrition includes being undernourished, overweight or obese, having inadequate vitamins or minerals, and having a non-communicable disease due to a bad diet. According to a Specialized Nutrition Europe study, nearly 40% of hospitalized adult patients were malnourished in Europe in 2019. Nutritional support delivered through enteral & parenteral means, depending on the need, is an important and appropriate way of treating most malnutrition cases. Thus, the huge burden of malnutrition in children and adults drives the demand for enteral and parenteral nutrition formulae and products. Preterm birth refers to a baby being born too early, i.e., before the completion of 37 weeks of pregnancy. As per the WHO data published in 2023, ~13.4 million preterm birth (more than 1 in 10 births) were reported worldwide in 2020. Most medical guidelines advise enteral nutrition for supporting the optimal growth of preterm infants if they are unable to drink, suck, swallow, and breathe, also parenteral nutrition is preferred in such babies due to sucking or swallowing difficulties as a complication of an immature birth or due to neuromuscular, heart, or other disorders. Hence, with the high number of preterm births, the demand for enteral and parenteral medical nutrition is on the rise in the region.

Europe Enteral and Parenteral Medical Nutrition Market Overview

The Europe enteral and parenteral medical nutrition market is segmented into Germany, the UK, France, Italy, Spain, Poland, Switzerland, Sweden, Belgium, the Netherlands, and the Rest of Europe. Europe occupies a significant position in the Europe enteral and parenteral medical nutrition market and is estimated to register a robust growth rate over the forecast period. The market growth can be attributed to increasing geriatric population, rising incidence of chronic diseases and neurological disorders such as stroke and cerebral aneurysms, and product innovations by the players operating in the region.

 Europe Enteral and Parenteral Medical Nutrition Market Revenue and Forecast to 2028 (US$ Million)

Europe Enteral and Parenteral Medical Nutrition Strategic Insights

Strategic insights for the Europe Enteral and Parenteral Medical Nutrition provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Enteral and Parenteral Medical Nutrition Report Scope

Europe Enteral and Parenteral Medical Nutrition Regional Insights

The geographic scope of the Europe Enteral and Parenteral Medical Nutrition refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Europe Enteral and Parenteral Medical Nutrition Market Segmentation

The Europe enteral and parenteral medical nutrition market is segmented into indication, nutrition type, form, product type, route of administration, age group, and distribution channel, and country.

Based on indication, the Europe enteral and parenteral medical nutrition market is segmented into elderly, gastrointestinal disorders, diabetes, cancer, respiratory disorders, alzheimer’s disease, dementia, renal disease, liver failure, post covid-19, and other indications. The elderly segment held the largest share of the Europe enteral and parenteral medical nutrition market in 2023. Gastrointestinal disorders are segmented into IBD, IBS, and others.

Based on nutrition type, the Europe enteral and parenteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held a larger share of the Europe enteral and parenteral medical nutrition market in 2023.

Based on form, the Europe enteral and parenteral medical nutrition market is segmented into liquid, powder, and semi solid. The liquid segment held the largest share of the Europe enteral and parenteral medical nutrition market in 2023.

Based on product type, the Europe enteral and parenteral medical nutrition market is segmented into general and disease specific. The general segment held the largest share of the Europe enteral and parenteral medical nutrition market in 2023.

Based on route of administration, the Europe enteral and parenteral medical nutrition market is segmented into oral, tube feed, and parenteral. The parenteral segment held the largest share of the Europe enteral and parenteral medical nutrition market in 2023.

Based on age group, the Europe enteral and parenteral medical nutrition market is segmented into above 60 years, 18-60 years, 3-18 years, and below 3 years. The above 60 years segment held the largest share of the Europe enteral and parenteral medical nutrition market in 2023.

Based on distribution channel, the Europe enteral and parenteral medical nutrition market is segmented into a hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest share of the Europe enteral and parenteral medical nutrition market in 2023

Based on country, the Europe enteral and parenteral medical nutrition market is segmented into Germany, the UK, France, Italy, Spain, Poland, Switzerland, Sweden, Belgium, the Netherlands, and the Rest of Europe. Germany dominated the share of the Europe enteral and parenteral medical nutrition market in 2023.   

Abbott Laboratories; AYMES International Ltd; B. Braun SE; Baxter International Inc; Charing Cross Scientific AS; Fresenius Kabi AG; Medifood International SA; Nestle SA; Nutricia International BV; and Smartfish AS are some of the leading companies operating in the Europe enteral and parenteral medical nutrition market.